Drug Price Regulation, B.C. Reg. 344/2012

Section 9

Maximum payment for non-reference drugs

Cite as Drug Price Regulation, B.C. Reg. 344/2012, s. 9 · last amended March 1, 2026 · read from BC Laws on November 17, 2026

The text

(1) The maximum amount the minister may pay for a non-reference drug that is not subject to the LCA program is the lesser of (a) the sum of the manufacturer's list price for the drug and 8% of that price, and (b) the maximum daily amount the minister may pay for the reference drug comparator for the reference drug category to which the non-reference drug belongs, as if the reference drug comparator were being dispensed at the daily therapeutic dose determined under section 6 (5) [reference drug program]. (2) The maximum amount the minister may pay for a non-reference drug that is subject to the LCA program is the lesser of (a) the amount determined under subsection (1), as if the non-reference drug were not subject to the LCA program, and (b) either, (i) if there are no provisional drugs in the LCA category to which the non-reference drug belongs, the sum of the maximum accepted list price for the LCA category to which the drug belongs and 8% of that price, or (ii) if there are provisional drugs in the LCA category to which the non-reference drug belongs, the maximum amount the minister may pay for a drug under section 11 (4) [prices for other drugs].
Read the Drug Price Regulation on BC Laws ↗

Made under Pharmaceutical Services Act, SBC 2012, c. 22.